chr9-135548765-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014582.3(OBP2A):āc.446A>Gā(p.His149Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000508 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_014582.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OBP2A | NM_014582.3 | c.446A>G | p.His149Arg | missense_variant | 5/7 | ENST00000371776.6 | NP_055397.1 | |
OBP2A | NM_001293189.2 | c.511A>G | p.Thr171Ala | missense_variant | 5/7 | NP_001280118.1 | ||
OBP2A | NM_001293193.2 | c.377A>G | p.His126Arg | missense_variant | 4/6 | NP_001280122.1 | ||
OBP2A | NR_120603.2 | n.550A>G | non_coding_transcript_exon_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OBP2A | ENST00000371776.6 | c.446A>G | p.His149Arg | missense_variant | 5/7 | 1 | NM_014582.3 | ENSP00000360841.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251444Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135896
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461752Hom.: 0 Cov.: 49 AF XY: 0.0000413 AC XY: 30AN XY: 727186
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74298
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at